Lv11
40 积分 2026-01-26 加入
No Evidence of QTc Interval Prolongation With Baxdrostat Treatment
1小时前
已关闭
Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
4个月前
已完结
Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study
4个月前
已完结
皖公网安备34019202002308
